DK3334425T3 - Methods of treatment or prevention of acute brain or nerve injuries - Google Patents
Methods of treatment or prevention of acute brain or nerve injuries Download PDFInfo
- Publication number
- DK3334425T3 DK3334425T3 DK16757422.7T DK16757422T DK3334425T3 DK 3334425 T3 DK3334425 T3 DK 3334425T3 DK 16757422 T DK16757422 T DK 16757422T DK 3334425 T3 DK3334425 T3 DK 3334425T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- methods
- acute brain
- nerve injuries
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562205431P | 2015-08-14 | 2015-08-14 | |
| PCT/US2016/046794 WO2017030968A1 (en) | 2015-08-14 | 2016-08-12 | Methods of treatment or prevention of acute brain or nerve injuries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3334425T3 true DK3334425T3 (da) | 2021-02-22 |
Family
ID=56801810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16757422.7T DK3334425T3 (da) | 2015-08-14 | 2016-08-12 | Methods of treatment or prevention of acute brain or nerve injuries |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20180228771A1 (da) |
| EP (1) | EP3334425B1 (da) |
| JP (1) | JP6862446B2 (da) |
| CN (1) | CN107921024B (da) |
| AU (1) | AU2016309815B2 (da) |
| CA (1) | CA2994974C (da) |
| DK (1) | DK3334425T3 (da) |
| HK (1) | HK1253901A1 (da) |
| TW (1) | TW201717938A (da) |
| WO (1) | WO2017030968A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3083015A1 (en) | 2017-05-24 | 2018-11-28 | Qr Pharma, Inc. | Prevention or treatment of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
| ES2275670T3 (es) * | 2000-03-03 | 2007-06-16 | EISAI R&D MANAGEMENT CO., LTD. | Metodos novedosos utilizando inhibidores de colinesterasa. |
| AU2003298514A1 (en) * | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
| US20120225922A1 (en) * | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
-
2016
- 2016-08-12 DK DK16757422.7T patent/DK3334425T3/da active
- 2016-08-12 US US15/751,337 patent/US20180228771A1/en active Pending
- 2016-08-12 AU AU2016309815A patent/AU2016309815B2/en active Active
- 2016-08-12 EP EP16757422.7A patent/EP3334425B1/en active Active
- 2016-08-12 CA CA2994974A patent/CA2994974C/en active Active
- 2016-08-12 TW TW105125790A patent/TW201717938A/zh unknown
- 2016-08-12 CN CN201680046586.2A patent/CN107921024B/zh active Active
- 2016-08-12 WO PCT/US2016/046794 patent/WO2017030968A1/en active Application Filing
- 2016-08-12 JP JP2018527851A patent/JP6862446B2/ja active Active
-
2018
- 2018-10-12 HK HK18113049.4A patent/HK1253901A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016309815B2 (en) | 2022-04-07 |
| CA2994974C (en) | 2024-04-09 |
| AU2016309815A1 (en) | 2018-02-15 |
| CN107921024B (zh) | 2021-09-10 |
| EP3334425B1 (en) | 2020-12-16 |
| TW201717938A (zh) | 2017-06-01 |
| US20180228771A1 (en) | 2018-08-16 |
| JP2018523709A (ja) | 2018-08-23 |
| HK1253901A1 (zh) | 2019-07-05 |
| WO2017030968A1 (en) | 2017-02-23 |
| CA2994974A1 (en) | 2017-02-23 |
| CN107921024A (zh) | 2018-04-17 |
| EP3334425A1 (en) | 2018-06-20 |
| JP6862446B2 (ja) | 2021-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006746B (en) | Methods of treatment | |
| IL285151A (en) | Methods for the treatment of fgf21-related disorders | |
| DK3285803T3 (da) | Fremgangsmåder til behandling eller forebyggelse af migrænehovedpine | |
| HK1251166A1 (zh) | 平滑肌肉瘤的靶向療法 | |
| IL293712A (en) | Methods for treating mild brain injury | |
| IL253889A0 (en) | Detection of brain damage | |
| IL251262A0 (en) | Methods for treating traumatic brain injury | |
| IL290069A (en) | Methods for treating eye conditions | |
| SG11201700530PA (en) | Agent for improving brain function and agent for preventing or treating cognitive impairment | |
| HK1249865B (zh) | 疼痛的治療 | |
| IL267229A (en) | Methods of treating ocular disorders | |
| IL250658A0 (en) | Methods for treating mild brain injury | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| PL3183003T3 (pl) | SPOSOBY ZAPOBIEGANIA l/LUB LECZENIA ZAKAŻENIA | |
| GB201602802D0 (en) | Method of treatment | |
| BR112017011891A2 (pt) | métodos de prevenção, redução ou tratamento de degeneração macular | |
| HK1243937A1 (zh) | 治療疾病的方法 | |
| HK1253901A1 (zh) | 治療或預防急性腦或神經損傷的方法 | |
| BR112016028653A2 (pt) | métodos de tratamento de doenças e distúrbios neurodesenvolvimentais | |
| FI20145861A (fi) | Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä | |
| SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
| GB201604359D0 (en) | Treatment of tissue disorders | |
| GB201512139D0 (en) | Methods of treatment | |
| GB201621398D0 (en) | Treatment of emt-associated disease | |
| SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases |